top of page

Integrated Market Access Solutions

We developed a systematic approach ensuring no critical milestone is overlooked. Every stakeholder alignment point is mapped, every regulatory pathway optimized, every payer objection anticipated.

Succesful

120+

Submissions

BENELUX SERVICED

3

Countries

leadership

25+

Year Experience

comMitment

100 %

Excellence

Reimbursed Patient
Access

Axes Health leads biotech and pharmaceutical companies from navigating pricing, reimbursement, and early access pathways to bring innovative therapies to BeNeLux patients in a sustainable way.

02

Our expertise

Navigating Pricing & Reimbursement,Guided Patient Access and Real-World Data

01

Our Purpose

Bringing innovative medicines of pharmaceutical and biotech companies to patients, sustainably and meaningfully

03

Our approach

Strategic engagement and executional excellence with deep respect for the patient’s voice.

Our Mission

Support in Patient Access

Our Services

How We Service our cutomers

01

Guided Patient Access

We build localised value stories, providingend-to-end supportfrom early access to reimbursement.

AdobeStock_170980846_edited_edited.jpg

02

Pricing & Reimbursement

We deliver strategic, landscape-driven access planning that minimises delays and rejections, facilitates early stakeholder dialogue, and embeds patient priorities at the core of your access strategy.

AdobeStock_170980846_edited_edited.jpg

03

Real World Data

We design and implement Belgium-specific real-world evidence pilots, identifying the right registries and clinical partners while integrating meaningful patient-reported outcomes to strengthen your value proposition.

AdobeStock_170980846_edited_edited.jpg

Our Integrated Approach

A systematic approach ensuring no critical milestone is overlooked, from early-stage development to post-launch optimisation.

1

Landscape Assessment

An in-depth analysis of the current landscape, unmet needs, and payer perceptions.

2

Value Proposition

Crafting a compelling value story and gathering necessary clinical and economic evidence.

3

Strategy Development

Defining the optimal pricing, contracting, and access strategy for each target market.

4

Execution & Launch

Following up on addressing clinical and budgetary uncertainties to maintain patient access.

Therapeutic Domains

We  bring extensive experience across a broad range of therapeutic domains

Orphan Diseases

Neurology

Respiratory

Dermatology

Oncology

Cardiology

Haematology

Nephrology

Why Choose  Axes Health? 

Strategic engagement and executional excellence with deep respect for the patient's voice.

Recognised executional excellence in delivering complex market access strategies across BeNeLux markets.

Deep respect for the patient's voice integrated throughout all our strategic planning and execution.

Unmatched expertise in rare diseases with proven track records across orphan disease portfolios.

Respected partner by health authorities with established relationships across European regulatory bodies.

bottom of page